Back to DE D. E. Shaw & Co., Inc.
NKTRShowing 4 of 27 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in Nektar Therapeutics
D. E. Shaw & Co., Inc. previously held 0 shares of NKTR (Nektar Therapeutics), worth $0 as of 2025-Q2.
Final Value
$0
Final Shares
0
Total Value Change
-$62,054
Total Shares Change
-47,734
Quarter-by-Quarter History
Other major holders of NKTR: BNP PARIBAS FINANCIAL MARKETS, Invesco Ltd., PRIMECAP MANAGEMENT CO/CA/